SEC 13F Intelligence

XERIS BIOPHARMA HOLDINGS INC

CUSIP 98422LAA5

Xeris Biopharma Holdings Inc has 6 institutional holders in Filings Flow’s 13F database, together reporting 44.67M shares worth $30M as of Q4 2022. The largest reported holders are Lazard Asset Management LLC, 683 Capital Management, LLC, and Concourse Financial Group Securities, Inc..

Institutional Holders
6
Q4 2022
Reported Value
$30M
Ticker
unmapped
private placement or foreign
Quarters Tracked
3

Ownership Trend

Institutional holders
Q2 ’21: 6Q2 ’21Q4 ’21: 6Q4 ’21Q4 ’22: 6Q4 ’22filingsflow.com
Total reported value
Q2 ’21: $74MQ2 ’21Q4 ’21: $57MQ4 ’21Q4 ’22: $30MQ4 ’22filingsflow.com

Holders

Mixed quarters
Export to Excel
Manager% of PortfolioValueSharesQuarter
683 Capital Management, LLC$1.9B AUM0.25%$4M3.20MQ4 2024OLDER
LAZARD ASSET MANAGEMENT LLC$60.8B AUM0.03%$21M11.50MQ1 2025OLDER

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.